BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 26768570)

  • 1. Design and analysis considerations in the Ebola_Tx trial evaluating convalescent plasma in the treatment of Ebola virus disease in Guinea during the 2014-2015 outbreak.
    Edwards T; Semple MG; De Weggheleire A; Claeys Y; De Crop M; Menten J; Ravinetto R; Temmerman S; Lynen L; Bah EI; Smith PG; van Griensven J;
    Clin Trials; 2016 Feb; 13(1):13-21. PubMed ID: 26768570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of Convalescent Plasma for Ebola Virus Disease in Guinea.
    van Griensven J; Edwards T; de Lamballerie X; Semple MG; Gallian P; Baize S; Horby PW; Raoul H; Magassouba N; Antierens A; Lomas C; Faye O; Sall AA; Fransen K; Buyze J; Ravinetto R; Tiberghien P; Claeys Y; De Crop M; Lynen L; Bah EI; Smith PG; Delamou A; De Weggheleire A; Haba N;
    N Engl J Med; 2016 Jan; 374(1):33-42. PubMed ID: 26735992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea.
    Sissoko D; Laouenan C; Folkesson E; M'Lebing AB; Beavogui AH; Baize S; Camara AM; Maes P; Shepherd S; Danel C; Carazo S; Conde MN; Gala JL; Colin G; Savini H; Bore JA; Le Marcis F; Koundouno FR; Petitjean F; Lamah MC; Diederich S; Tounkara A; Poelart G; Berbain E; Dindart JM; Duraffour S; Lefevre A; Leno T; Peyrouset O; Irenge L; Bangoura N; Palich R; Hinzmann J; Kraus A; Barry TS; Berette S; Bongono A; Camara MS; Chanfreau Munoz V; Doumbouya L; Souley Harouna ; Kighoma PM; Koundouno FR; Réné Lolamou ; Loua CM; Massala V; Moumouni K; Provost C; Samake N; Sekou C; Soumah A; Arnould I; Komano MS; Gustin L; Berutto C; Camara D; Camara FS; Colpaert J; Delamou L; Jansson L; Kourouma E; Loua M; Malme K; Manfrin E; Maomou A; Milinouno A; Ombelet S; Sidiboun AY; Verreckt I; Yombouno P; Bocquin A; Carbonnelle C; Carmoi T; Frange P; Mely S; Nguyen VK; Pannetier D; Taburet AM; Treluyer JM; Kolie J; Moh R; Gonzalez MC; Kuisma E; Liedigk B; Ngabo D; Rudolf M; Thom R; Kerber R; Gabriel M; Di Caro A; Wölfel R; Badir J; Bentahir M; Deccache Y; Dumont C; Durant JF; El Bakkouri K; Gasasira Uwamahoro M; Smits B; Toufik N; Van Cauwenberghe S; Ezzedine K; D'Ortenzio E; Pizarro L; Etienne A; Guedj J; Fizet A; Barte de Sainte Fare E; Murgue B; Tran-Minh T; Rapp C; Piguet P; Poncin M; Draguez B; Allaford Duverger T; Barbe S; Baret G; Defourny I; Carroll M; Raoul H; Augier A; Eholie SP; Yazdanpanah Y; Levy-Marchal C; Antierrens A; Van Herp M; Günther S; de Lamballerie X; Keïta S; Mentre F; Anglaret X; Malvy D;
    PLoS Med; 2016 Mar; 13(3):e1001967. PubMed ID: 26930627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Convalescent plasma: new evidence for an old therapeutic tool?
    Marano G; Vaglio S; Pupella S; Facco G; Catalano L; Liumbruno GM; Grazzini G
    Blood Transfus; 2016 Mar; 14(2):152-7. PubMed ID: 26674811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical research during the Ebola virus disease outbreak in Guinea: Lessons learned and ways forward.
    Beavogui AH; Delamou A; Yansane ML; Konde MK; Diallo AA; Aboulhab J; Bah-Sow OY; Keita S
    Clin Trials; 2016 Feb; 13(1):73-8. PubMed ID: 26768557
    [No Abstract]   [Full Text] [Related]  

  • 6. Organizing the Donation of Convalescent Plasma for a Therapeutic Clinical Trial on Ebola Virus Disease: The Experience in Guinea.
    Delamou A; Haba NY; Mari-Saez A; Gallian P; Ronse M; Jacobs J; Camara BS; Kadio KJO; Guemou A; Kolie JP; Crop M; Chavarin P; Jacquot C; Lazaygues C; Weggheleire A; Lynen L; van Griensven J
    Am J Trop Med Hyg; 2016 Sep; 95(3):647-653. PubMed ID: 27430546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment-donation-stockpile dynamics in ebola convalescent blood transfusion therapy.
    Huo X; Sun X; Lan K; Wu J
    J Theor Biol; 2016 Mar; 392():53-61. PubMed ID: 26721704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Taking the bull by the horns: Ethical considerations in the design and implementation of an Ebola virus therapy trial.
    Kombe F; Folayan MO; Ambe J; Igonoh A; Abayomi A;
    Soc Sci Med; 2016 Jan; 148():163-70. PubMed ID: 26653137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute respiratory distress syndrome after convalescent plasma use: treatment of a patient with Ebola virus disease contracted in Madrid, Spain.
    Mora-Rillo M; Arsuaga M; Ramírez-Olivencia G; de la Calle F; Borobia AM; Sánchez-Seco P; Lago M; Figueira JC; Fernández-Puntero B; Viejo A; Negredo A; Nuñez C; Flores E; Carcas AJ; Jiménez-Yuste V; Lasala F; García-de-Lorenzo A; Arnalich F; Arribas JR;
    Lancet Respir Med; 2015 Jul; 3(7):554-62. PubMed ID: 26041403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial.
    Henao-Restrepo AM; Longini IM; Egger M; Dean NE; Edmunds WJ; Camacho A; Carroll MW; Doumbia M; Draguez B; Duraffour S; Enwere G; Grais R; Gunther S; Hossmann S; Kondé MK; Kone S; Kuisma E; Levine MM; Mandal S; Norheim G; Riveros X; Soumah A; Trelle S; Vicari AS; Watson CH; Kéïta S; Kieny MP; Røttingen JA
    Lancet; 2015 Aug; 386(9996):857-66. PubMed ID: 26248676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of convalescent plasma to treat emerging infectious diseases: focus on Ebola virus disease.
    Winkler AM; Koepsell SA
    Curr Opin Hematol; 2015 Nov; 22(6):521-6. PubMed ID: 26457963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ebola outbreak in Conakry, Guinea: epidemiological, clinical, and outcome features.
    Barry M; Traoré FA; Sako FB; Kpamy DO; Bah EI; Poncin M; Keita S; Cisse M; Touré A
    Med Mal Infect; 2014 Dec; 44(11-12):491-4. PubMed ID: 25391486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Use of Ebola Convalescent Plasma to Treat Ebola Virus Disease in Resource-Constrained Settings: A Perspective From the Field.
    van Griensven J; De Weiggheleire A; Delamou A; Smith PG; Edwards T; Vandekerckhove P; Bah EI; Colebunders R; Herve I; Lazaygues C; Haba N; Lynen L
    Clin Infect Dis; 2016 Jan; 62(1):69-74. PubMed ID: 26261205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of convalescent whole blood for treating Ebola Virus Disease in Freetown, Sierra Leone.
    Sahr F; Ansumana R; Massaquoi TA; Idriss BR; Sesay FR; Lamin JM; Baker S; Nicol S; Conton B; Johnson W; Abiri OT; Kargbo O; Kamara P; Goba A; Russell JB; Gevao SM
    J Infect; 2017 Mar; 74(3):302-309. PubMed ID: 27867062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What motivates Ebola survivors to donate plasma during an emergency clinical trial? The case of Ebola-Tx in Guinea.
    Ronse M; Marí Sáez A; Gryseels C; Bannister-Tyrrell M; Delamou A; Guillard A; Briki M; Bigey F; Haba N; van Griensven J; Peeters Grietens K
    PLoS Negl Trop Dis; 2018 Oct; 12(10):e0006885. PubMed ID: 30332421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogen-reduced Ebola virus convalescent plasma: first steps towards standardization of manufacturing and quality control including assessment of Ebola-specific neutralizing antibodies.
    Geisen C; Kann G; Strecker T; Wolf T; Schüttfort G; van Kraaij M; MacLennan S; Rummler S; Weinigel C; Eickmann M; Fehling SK; Krähling V; Seidl C; Seifried E; Schmidt M; Schäfer R
    Vox Sang; 2016 May; 110(4):329-35. PubMed ID: 26766162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical trials during the Ebola crisis.
    Dodd LE
    Clin Trials; 2016 Feb; 13(1):5. PubMed ID: 26768571
    [No Abstract]   [Full Text] [Related]  

  • 18. Challenges in preparing and implementing a clinical trial at field level in an Ebola emergency: A case study in Guinea, West Africa.
    Carazo Perez S; Folkesson E; Anglaret X; Beavogui AH; Berbain E; Camara AM; Depoortere E; Lefevre A; Maes P; Malme KN; Malvy JD; Ombelet S; Poelaert G; Sissoko D; Tounkara A; Trbovic P; Piguet P; Antierens A
    PLoS Negl Trop Dis; 2017 Jun; 11(6):e0005545. PubMed ID: 28640812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of convalescent plasma in Ebola virus infection.
    Garraud O
    Transfus Apher Sci; 2017 Feb; 56(1):31-34. PubMed ID: 28094110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The ongoing evolution of antibody-based treatments for Ebola virus infection.
    Mendoza EJ; Racine T; Kobinger GP
    Immunotherapy; 2017 Mar; 9(5):435-450. PubMed ID: 28357917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.